Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body clinical trial (NCT03955939). Contact the study team or your healthcare provider for specific answers.

Question 2

How does LY3295668 erbumine compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body clinical trial (NCT03955939). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body clinical trial (NCT03955939). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body clinical trial (NCT03955939). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer progresses during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body clinical trial (NCT03955939). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body clinical trial (NCT03955939). Contact the study team or your healthcare provider for specific answers.

What this study is about